Chordate Medical säger upp likviditetsgarantin för preferensaktien

Chordate Medical meddelar härmed att bolaget har sagt upp avtalet med Lago Kapital om uppdraget som likviditetsgarant för preferensaktien CMH Pref.

Syftet med likviditetsgarant har varit att främja likviditeten i bolagets preferensaktie, minska volatiliteten samt underlätta handel. Chordate Medical bedömer att rådande handel och likviditet i aktien är god och att nyttan av likviditetsgarant är begränsad.

Likviditetsgarantin upphör 2025-06-17.

Chordate Medical terminates the liquidity provider agreement for the preference share

Chordate Medical hereby announces that the company has terminated the agreement with Lago Kapital regarding the assignment as liquidity provider for the preference share CMH Pref.

The purpose of the liquidity provider has been to promote the liquidity of the company's preference share, reduce volatility and facilitate trading. Chordate Medical assesses that the current trading and liquidity in the share is good and that the benefit of the liquidity provider is limited.

The liquidity guarantee expires on 2025-06-17.

Byte av Certified Adviser (CA) till Bergs Securities

Chordate Medical meddelar härmed att bolaget har ingått avtal med Bergs Securities AB avseende tjänsten som Certified Adviser. Bergs Securities tillträder som Certified Adviser (CA) den 2 maj 2025. Fram till dess kommer Vator Securities AB att fortsatt agera Certified Adviser åt bolaget.

Change of Certified Adviser (CA) to Bergs Securities

Chordate Medical hereby announces that the company has entered into an agreement with Bergs Securities AB for the role of Certified Adviser. Bergs Securities will assume the position of Certified Adviser (CA) on May 2, 2025. Until then, Vator Securities AB will continue to serve as the company’s Certified Adviser.